semaglutide and cirrhosis targets MASH molecular pathways beyond weight loss Semaglutide 2·4 mg once weekly

The medication's Summary of Product Characteristics (SmPC) does not list male infertility or reduced sperm quality as recognised adverse effects

Salas-Whalen echoes the same idea

2012;4:CD006282

These drugs work by imitating glucagon-like peptide-1 (GLP-1), a growth hormone that triggers insulin release, reduces blood sugar levels, slows the progress of food along the intestinal track, and stimulates parts of the brain that control craving and satiety

Recalls & Warnings October 24, 2003 Court Closes the Doors on Company That Sold Weight Loss Supplement On October 24, 2003, the Federal Trade Commission (FTC)announced that Mark Nutritionals, Inc